Eli Lilly’s Alzheimer’s disease drug is approved by the US FDA
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s early-stage Alzheimer’s disease treatment, making it the second treatment to slow the progression of the brain-loss-causing disease to be made available to patients in the United States.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO